Scarica l'app Stockscreener
3.69
0.27%
-0.01
Dopo l'orario di chiusura:
3.68
-0.010
-0.27%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Eledon Pharmaceuticals Inc Borsa (ELDN) Ultime notizie
Is Eledon Pharmaceuticals Inc. a good long term investmentFree Stock Chart Pattern Guide - PrintWeekIndia
What analysts say about Eledon Pharmaceuticals Inc. stockExceptional market performance - Autocar Professional
Eledon Pharmaceuticals Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com
What drives Eledon Pharmaceuticals Inc. stock priceDynamic capital growth - jammulinksnews.com
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b - GlobeNewswire
Eledon to present updated kidney transplant study data at WTC By Investing.com - Investing.com South Africa
New Phase 1b Data: Tegoprubart Shows Promise in Preventing Kidney Transplant Rejection30 Patient Update - Stock Titan
How Eledon Pharmaceuticals Inc. stock performs during market volatilityFree Group Entry - Newser
Why Eledon Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
What makes Eledon Pharmaceuticals Inc. stock price move sharplyWealth Accumulation Stock List - Newser
Best Momentum Stocks to Buy for July 14th - TradingView
What is Lifesci Capital’s Estimate for ELDN Q2 Earnings? - Defense World
Midday Stock Roundup: Irvine’s Eledon Pharmaceuticals Jump 17% - Orange County Business Journal
Cantor Fitzgerald reiterates Overweight rating on Eledon Pharmaceuticals stock By Investing.com - Investing.com Canada
Eledon Pharmaceuticals Rings the Closing Bell - Nasdaq
Extending Transplant Life Through Targeted Innovation - the-scientist.com
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | SEOVF Stock News - GuruFocus
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes - The Manila Times
Breakthrough: New Drug Collaboration Shows 5X Better Results in Type 1 Diabetes Cure Trial - Stock Titan
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) high institutional ownership speaks for itself as stock continues to impress, up 12% over last week - simplywall.st
Eledon Pharmaceuticals, Inc.(NasdaqCM:ELDN) added to Russell Small Cap Comp Growth Index - MarketScreener
Eledon stock rating reiterated as Overweight by Cantor Fitzgerald - Investing.com Canada
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New Yo - GuruFocus
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City - Business Upturn
Eledon Pharmaceuticals: A Transplant Breakthrough on the Horizon? - AInvest
What is HC Wainwright’s Estimate for ELDN Q2 Earnings? - Defense World
What is HC Wainwright’s Estimate for ELDN Q1 Earnings? - Defense World
Eledon Pharmaceuticals (NASDAQ:ELDN) Rating Increased to Buy at HC Wainwright - Defense World
ELDN: HC Wainwright & Co. Sets New Price Target for Eledon Pharm - GuruFocus
H.C. Wainwright assumes coverage on Eledon stock with buy rating By Investing.com - Investing.com UK
H.C. Wainwright Reaffirms Buy Rating for Eledon Pharmaceuticals - GuruFocus
Bank of America Corp DE Increases Stock Holdings in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Eledon Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Millennium Management LLC Invests $490,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Eledon Pharmaceuticals (NASDAQ:ELDN) Rating Lowered to Sell at Wall Street Zen - Defense World
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 12.3% - Defense World
Northern Trust Corp Boosts Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Jane Street Group LLC Makes New $504,000 Investment in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock - MSN
Eledon Pharmaceuticals Reports Q1 2025 Progress and Financials - TipRanks
What is Noble Financial’s Estimate for ELDN Q2 Earnings? - Defense World
Cubist Systematic Strategies LLC Takes $101,000 Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Balyasny Asset Management L.P. Invests $134,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):